PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are a current or former member of the military and are at least 18 years old
- People who have been diagnosed with at least one anxiety-related condition, such as Post-Traumatic Stress Disorder (PTSD), Panic Disorder, Social Anxiety Disorder, or Generalized Anxiety Disorder, among others (based on a specific clinical interview)
- People whose enjoyment of life and overall satisfaction is rated as moderate to poor, based on a specific questionnaire score of 47 or lower
- People who have been on the same psychiatric medication(s) for at least 4 weeks before the study begins
- People who are willing to be randomly assigned to one of the treatment groups in the study
Who may not be able to join:
- People who are currently experiencing active symptoms of mania or psychosis at the start of the study
- People who are experiencing depression with active thoughts of suicide and a plan to act on them, where this would make treatment unsafe
- People with moderate-to-severe difficulties with memory or thinking, based on a specific cognitive assessment score below 20
- People who use alcohol or substances during treatment and are not willing to reduce and limit that use, particularly during the exposure-based parts of the treatment (those who do agree to reduce use may still be eligible)
- People who are already receiving a type of talk therapy called transdiagnostic Cognitive Behavioural Therapy (CBT) that specifically targets any of the anxiety-related conditions listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ellen Teng, PhD, Michael E. DeBakey VA Medical Center
Phone: (713) 791-1414
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Quality of Life score on the Quality of Life Enjoyment & Satisfaction Questionnaire Short-Form (QLES-Q-SF) from Baseline to 6-Month Follow-Up between the iTCBT conditions (Individual & Group) and TAU.; Change in Anxiety score on the Beck Anxiety Inventory (BAI) from Baseline to 6-Month Follow-Up between the iTCBT conditions (Individual & Group) and TAU.; Change in Quality of Life score on the Quality of Life Enjoyment & Satisfaction Questionnaire Short-Form (QLES-Q-SF) from Baseline to 6-Month Follow-Up between the iTCBT Enhanced (iTCBT-E) condition and TAU.; Change in Anxiety score...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.